Audentes Therapeutics, Inc. Business Combination, Contingent Consideration, Liability, Noncurrent
Audentes Therapeutics, Inc. had Business Combination, Contingent Consideration, Liability, Noncurrent of $2.46 million as of 2019-09-30, per its 10-Q filed 2019-11-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2019-11-07
- 2019-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $2.46M.
- 2019-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $2.40M.
- 2019-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $2.32M.
- 2018-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00; Business Combination, Contingent Consideration, Liability, Noncurrent as first filed $2.35M.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent as first filed |
|---|---|---|
| 2019-09-30 | $2.46M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $2.40M 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $2.32M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-07 | $2.35M 10-K · filed 2019-03-01 |
| 2018-09-30 | $2.32M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $2.30M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $2.36M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $4.64M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $4.54M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $4.54M 10-Q · filed 2017-08-10 | |
| 2017-03-31 | $4.47M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $4.38M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $4.57M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $4.46M 10-Q · filed 2016-09-01 | |
| 2015-12-31 | $4.28M 10-K · filed 2017-03-13 |